Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Bullboard Posts
Comment by snuff69on Nov 20, 2018 12:40pm
83 Views
Post# 29000401

RE:RE:RE:good november

RE:RE:RE:good novemberThe way i see it is theres still selling the 2d full systems as 
98% of all echocardiograms are done with 2D, which is our primary product, the VMs +system. Then as technolgy blossoms as it always does and the big players are
always one step ahead , hes hoping to have the 3d technolgy to
run in all the big players equipement .Your telling me that if vpt
had the software to sell to the big companys to run in every system
worldwide sales would be down . I think its great that there trying to stay
one step ahead of the big players and hes talking a decade down the road
when 3d will be the go to for echocardiograms



Our business today is still focused on selling VMS+ systems (hardware and software) for 2D use, but eventually we expect the major vendors (GE, Siemens, Phillips, Mindray, Samsung, Hitachi, Toshiba) to improve the 3D hardware to obtain 70-80% readable images and then our business will switch to selling software only most of the time, but there will still be a need for the VMS+ hardware 20-30% of the time, so we will be selling both products to cardiac hospitals.



Bullboard Posts